Similarly, overexpression of AKR1B10 was documented in hepatocellular carcinoma [76], breast [31,64,77], pancreatic [78], and lung cancer [79] with significant downregulation in CRC [80]. Here, AKR1B10 is linked to colorectal carcinoma.